BiomX (PHGE)
(Delayed Data from AMEX)
$0.65 USD
+0.22 (49.43%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $0.53 -0.12 (-18.46%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PHGE 0.65 +0.22(49.43%)
Will PHGE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PHGE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHGE
BiomX (PHGE) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
BiomX Stock Gains From Favorable Study Data Presentation on BX004
PHGE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PHGE
12 Health Care Stocks Moving In Wednesday's Intraday Session
BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025 | ...
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Wednesday's After-Market Session